Dual-route levofloxacin delivery following revision surgery: a synergistic intravenous/intra-articular strategy for enhanced bactericidal effect against prosthetic Pseudomonas aeruginosa infections
Abstract
PURPOSE: Pseudomonas aeruginosa (PA)-associated periprosthetic joint infection (PJI) is notoriously difficult to treat due to biofilm formation and poor antibiotic penetration into joint tissues. This study investigates the efficacy of combined intravenous (IV) and intra-articular (IA) levofloxacin administration in targeting PA biofilms in PJI. METHODS: A retrospective cohort of nine knee PJI patients received daily IV (500 mg) and IA (100 mg) levofloxacin post-revision surgery. Patients were followed for ≥2 years for their long-term clinical outcomes, with synovial and serum levofloxacin concentrations analyzed to assess minimum biofilm eradication concentration (MBEC) attainment. Physiologically based pharmacokinetic (PBPK) modeling simulated levofloxacin distribution in plasma, synovial fluid, and synovium. In vitro studies quantified biofilm biomass and metabolic activity reduction, while scanning electron microscopy (SEM) evaluated biofilm disruption on three-dimensional (3D)-printed knee implants. RESULTS: Over 2 years, no patients required reoperation, experienced mortality, or needed ongoing antibiotic suppression. Daily living activities and Knee Society Scores improved, with no major adverse events. On postoperative day 7, synovial levofloxacin concentrations reached 110.20 ± 39.20 mg/L, exceeding the MBEC for 80% of PA isolates. Serum levofloxacin concentrations were measured at 1.76 ± 0.37 mg/L, showing only a marginal increase compared to the levels specified…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.